Your Trusted Source for Life Sciences Data
Discover emerging life science companies, uncover qualified leads, and identify the right partners faster. By combining expert human curation with AI-driven intelligence, our platform delivers the insights you need to accelerate business development, licensing, and investment decisions with confidence.
Unique data sourcing process
leading to an exclusive data set
Over 1,070,000 regularly
updated clinical trials
69,000 companies with over
380,000 management contact details
Over 42,000 Biotech, Pharma and Medtech
assets available for licensing
Investor Database including
direct contact details
License agreements with payment
structures and original contract
BIOTECHGATE DIGITAL PARTNERING
Virtual business development & licensing event
Join five days of digital partnering, workshops and networking sessions. Establish new global connections thanks to pre-arranged one-on-one Zoom meetings.
Solutions by industry
Biotechgate is a versatile information source
catering to the entire life science industry.
What our clients say
Latest industry news
Akiram Therapeutics: First clinical results from AKIR001 to be presented at EANM 2026
13 Oct 2026
Read moreGCCL and LabConnect Sign MOU to Expand Global Clinical Trial Collaboration
13 Oct 2026
Read moreContinuously Evolving Cells Help Pancreatic Cancer Evade Treatment and Spread
13 Oct 2026
Read moreUpcoming Conferences
20
October
2026
20
October
2026
AusBiotech Invest
Queensland, Australia
AusBiotech Invest is a core pillar of Australia’s Biggest Week in Biotech, a curated capital convening designed to strengthen the investment and capital environment around Australian life sciences. More than a company showcase or investor-matching exercise, this AusBiotech Invest event will on the Gold Coast will bring together active investors, capital partners and a specially selected high potential companies to explore investment opportunities, market insights, syndication pathways and the broader conditions required to fund and scale high-potential Australian innovation. The program is being shaped through ongoing engagement with investors and capital partners to ensure it delivers meaningful opportunities for discussion, connection and investment consideration.
Delegates from Venture Valuation and Biotechgate
will attend the event.
Read more
21
October
2026
23
October
2026
AusBiotech International Conference
Queensland, Australia
The AusBiotech International Conference is Australia’s largest biotechnology conference and part of Australia’s Biggest Week in Biotech, connecting local expertise with Australian and international partners to accelerate innovation and impact. Join us at the Gold Coast Convention & Exhibition Centre, Queensland, from 21 to 23 October, 2026. This October, AusBiotech International Conference will be presented alongside the AusMedtech Conference, connecting local expertise with Australian and international partners to accelerate innovation and impact. Your International Conference registration will include access to all AusMedtech events.
Delegates from Venture Valuation and Biotechgate
will attend the event.
Read more
27
October
2026
28
October
2026
BioFuture 2026
New York City, USA
BioFuture is where relentless therapeutic pioneers, innovators, and investors gather to assess and shape the future of healthcare and digital health. Participate in candid, unfiltered discussions. At this year’s summit, we’ll explore the exciting mashup between rapidly evolving fields including biopharma, digital medicine, big data, AI, healthcare systems, payors, and more. The coming decade will dramatically accelerate the transformation of the healthcare ecosystem. Be part of the discussions that will shape and transform the future of healthcare.
Delegates from Venture Valuation and Biotechgate
will attend the event.
Read more
04
November
2026
04
November
2026
Drug Discovery Innovators & Investors: London, UK
London, United Kingdom
Through expert-led discussions and networking, attendees will gain insights into the impact of AI and emerging technologies, access to early-stage capital, regulatory developments, and the strategies and partnerships needed to accelerate the path from discovery to patient impact.
Read more